NIH launches major study to uncover hidden causes of dangerous low blood sugar
NCT ID NCT00001276
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 7 times
Summary
This study aims to better understand why some people experience dangerously low blood sugar (hypoglycemia), especially after fasting. Researchers will admit 1,500 adults to the NIH Clinical Center for controlled fasting and a series of blood tests to measure insulin and other factors. The goal is to improve diagnosis and treatment for conditions like insulinoma, a tumor that causes excess insulin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do Younger-Age pancreatic tumors behave differently? a new study digs in
- Could a glucose monitor and education shield seniors from Insulin's dangerous side?
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Hidden sensor reveals dangerous blood sugar dips during routine eye surgery
- Could a simple sugar help people with type 1 diabetes exercise safely?
- Period power: study seeks to tame blood sugar swings in type 1 diabetes